Synthesis and hepatoprotective activity of 3,4 diacetyl; 3,4 dibenzyl caffeic and 4-(dimethylamino) cinnamic acids.
Pérez-Alvarez
Victor
V
Sección Externa de Farmacología, CINVESTAV IPN, Apartado Postal 14-740 México 07360 D.F., México. vperez@mail.cinvestav.mx
Fernández-Martinez
Eduardo
E
Morales-Ríos
Martha S
MS
Bobadilla
Rosa Amalia
RA
Muriel
Pablo
P
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers; D002109:Caffeic Acids / Q000494:pharmacology*; D002252:Carbon Tetrachloride Poisoning / Q000517:prevention & control*; D056486:Chemical and Drug Induced Liver Injury / Q000517:prevention & control*; D002934:Cinnamates / Q000494:pharmacology*; D015227:Lipid Peroxidation / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D051381:Rats; D017208:Rats, Wistar
C481009:3,4-diacetyl caffeic acid; C481010:3,4-dibenzyl caffeic acid; C481008:4-(dimethylamino)cinnamic acid; D015415:Biomarkers; D002109:Caffeic Acids; D002934:Cinnamates; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase